Late Effects of Cancer and Hematopoietic Stem-Cell Transplantation on Spouses or Partners Compared With Survivors and Survivor-Matched Controls

  • Michelle M. Bishop
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • Jennifer L. Beaumont
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • Elizabeth A. Hahn
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • David Cella
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • Michael A. Andrykowski
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • Marianne J. Brady
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • Mary M. Horowitz
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • Kathleen A. Sobocinski
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • J. Douglas Rizzo
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI
  • John R. Wingard
    From the Department of Medicine, University of Florida College of Medicine, Gainesville, FL; Center on Outcomes, Research and Education at Evanston Northwestern Healthcare, Evanston, IL; University of Kentucky College of Medicine, Lexington, KY; Independent Consultant, Trout Creek, MI; and Center for International Blood and Marrow Transplant Research, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI

抄録

<jats:sec><jats:title>Purpose</jats:title><jats:p> Little is known about the long-term effects of cancer and hematopoietic stem-cell transplantation (HCT) on spouses or partners. The purpose of this study was to examine the health-related quality of life and post-traumatic growth (PTG) of spouses/partners compared with survivors and controls and to identify factors associated with those outcomes. </jats:p></jats:sec><jats:sec><jats:title>Patients and Methods</jats:title><jats:p> HCT survivor/partner pairs (n = 177), coupled continuously since HCT, were drawn from 40 North American transplantation centers. Married peer-nominated acquaintances (of survivors) served as controls (n = 133). Outcomes were measured a mean of 6.7 years after HCT (range, 1.9 to 19.4 years). </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> As expected, self-reported partner physical health was similar to controls and better than survivors (P < .001). However, partners reported more fatigue and cognitive dysfunction than controls (P < .001 for both), although less than survivors. Partners and survivors reported more depressive symptoms and sleep and sexual problems than controls (P < .001, P < .01, and P < .01, respectively). Odds of partner depression were nearly 3.5 times that of controls (P < .002). Depressed partners were less likely than depressed survivors to receive mental health treatment (P < .04). Partners reported less social support (P < .001), dyadic satisfaction (P < .05), and spiritual well-being (P < .05) and more loneliness (P < .05) than both survivors and controls. In contrast to survivors, partners reported little PTG (P < .001). Factors associated with partner outcomes included partner health problems, coping, female sex, social constraint, survivor depression, optimism, multiple life changes, and social support. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> Spouses/partners experience similar emotional and greater social long-term costs of cancer and HCT than survivors without the potential compensatory benefits of PTG. Some of the factors associated with partner outcomes are amenable to intervention. </jats:p></jats:sec>

収録刊行物

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ